Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
4(44%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
22%
Ph phase_2
1
11%
Ph phase_3
4
44%
Ph phase_1
1
11%
Ph early_phase_1
1
11%

Phase Distribution

2

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
4(44.4%)
Phase 4Post-market surveillance
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(3)
Other(1)

Detailed Status

Recruiting3
Completed3
unknown1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 34 (44.4%)
Phase 42 (22.2%)

Trials by Status

recruiting333%
unknown111%
not_yet_recruiting111%
completed333%
active_not_recruiting111%

Recent Activity

4 active trials
Showing 5 of 9
recruitingphase_3

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

NCT04774159
not_yet_recruitingphase_3

Design and Rationale of the COLT Study

NCT07432529
active_not_recruitingphase_2

Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes

NCT05949281
completedphase_1

EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL

NCT06847204
recruitingphase_4

Prednisolone Versus Colchicine for Acute Gout in Primary Care

NCT05698680
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04774159Phase 3

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Recruiting
NCT07432529Phase 3

Design and Rationale of the COLT Study

Not Yet Recruiting
NCT05949281Phase 2

Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes

Active Not Recruiting
NCT06847204Phase 1

EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL

Completed
NCT05698680Phase 4

Prednisolone Versus Colchicine for Acute Gout in Primary Care

Recruiting
NCT06426537Early Phase 1

Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches

Completed
NCT06095765Phase 3

Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention

Recruiting
NCT05739929Phase 3

Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)

Unknown
NCT05200052Phase 4

Effect of Colchicine On Left Ventricle Function After Anterior Myocardial Infarction Assessed By Speckle Tracking

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9